WO2023053039 - NOVEL DIAMINOBENZIMIDAZOLE DERIVATIVE

National phase entry:
Publication Number WO/2023/053039
Publication Date 06.04.2023
International Application No. PCT/IB2022/059259
International Filing Date 28.09.2022
Title **
[English] NOVEL DIAMINOBENZIMIDAZOLE DERIVATIVE
[French] NOUVEAU DÉRIVÉ DE DIAMINOBENZIMIDAZOLE
Applicants **
CARNA BIOSCIENCES, INC. 1-5-5, Minatojima-Minamimachi Chuo-ku, Kobe-shi Hyogo 6500047, JP
Inventors
MATSUMOTO, Hirokazu c/o Carna Biosciences, Inc. 1-5-5, Minatojima-Minamimachi Chuo-ku, Kobe-shi Hyogo 6500047, JP
KIYOI, Takao c/o Carna Biosciences, Inc. 1-5-5, Minatojima-Minamimachi Chuo-ku, Kobe-shi Hyogo 6500047, JP
TAKAMATSU, Shiori c/o Carna Biosciences, Inc. 1-5-5, Minatojima-Minamimachi Chuo-ku, Kobe-shi Hyogo 6500047, JP
SAWA, Masaaki c/o Carna Biosciences, Inc. 1-5-5, Minatojima-Minamimachi Chuo-ku, Kobe-shi Hyogo 6500047, JP
Priority Data
2021-157615   28.09.2021   JP
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
*
International Searching Authority
*
Applicant's Legal Status
*
*
*
*
*
Entry into National Phase under
*
Translation

Recalculate

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing1596
EPO Filing, Examination10113
Japan Filing588
South Korea Filing574
USA Filing, Examination4310
MasterCard Visa

Total: 17181

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Abstract[English] are defined in the specification.[French] sont définis dans la description.
An unhandled error has occurred. Reload 🗙